Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: efficacy data from 2 randomized, double‐blind phase III studies
The efficacy of oral NEPA (netupitant‐palonosetron 300/0.50 mg) was evaluated from two randomized phase III studies in patients receiving HEC, AC, or MEC over multiple chemotherapy cycles. Oral NEPA ...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
09 April 2019
|
| In: |
Cancer medicine
Year: 2019, Jahrgang: 8, Heft: 5, Pages: 2064-2073 |
| ISSN: | 2045-7634 |
| DOI: | 10.1002/cam4.2091 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1002/cam4.2091 Verlag: https://onlinelibrary.wiley.com/doi/10.1002/cam4.2091 
|
| Verfasserangaben: | Lee Schwartzberg, Meinolf Karthaus, Giorgia Rossi, Giada Rizzi, Maria E. Borroni, Hope S. Rugo, Karin Jordan, Vincent Hansen |
| Zusammenfassung: | The efficacy of oral NEPA (netupitant‐palonosetron 300/0.50 mg) was evaluated from two randomized phase III studies in patients receiving HEC, AC, or MEC over multiple chemotherapy cycles. Oral NEPA ... |
|---|---|
| Beschreibung: | Gesehen am 25.11.2019 |
| Beschreibung: | Online Resource |
| ISSN: | 2045-7634 |
| DOI: | 10.1002/cam4.2091 |